Avalon GloboCare Corp. (NASDAQ: ALBT)

Avalon GloboCare Corp. is a technology innovation company that focuses on developing products and services for consumer health and artificial intelligence markets. The firm has evolved its business over time while maintaining its original mission and management team. It actively seeks complementary bolt on AI acquisitions that could generate near-term revenue to supplement current operations. The company's current operations are organized into two distinct business segments: a consumer health technology segment and an artificial intelligence content technology segment.

Revenue is derived mainly from the sale of the Keto Air breathalyzer device to consumers under an exclusive North American distribution agreement. The firm also earns income from the development and commercialization of its AI driven short form video generation platform, which may involve licensing arrangements, subscription fees or service charges. The Keto Air device is marketed through social media influencer relationships and a partnership with the Law Enforcement Association of America. The AI platform is currently in beta testing with a limited group of content creators, with plans to expand to a broader creator and marketer base after further development.

The company operates through the following segments: Consumer Health Technology and Artificial Intelligence Content Technology.

• Consumer Health Technology: This segment distributes the Keto Air breathalyzer device, a non invasive reusable consumer product that measures ketosis levels by analyzing breath, under an exclusive North American distribution agreement valid through July 2025; the device holds an FDA registration number and is not classified as a medical device requiring pre market approval.

• Artificial Intelligence Content Technology: This segment develops and commercializes an AI driven short form video generation platform through its subsidiary Avalon Quantum AI LLC, allowing creators to input a topic after which the system searches online for relevant video content, selects the most viewed or discussed material, and produces a three part video featuring an AI generated avatar that replicates the creator's voice and likeness; the platform is presently in beta testing with a limited group of users and a phase 2 upgrade slated for Q3 2026 will broaden the target audience to include social media influencers and marketers while enhancing avatar realism.

In the consumer health technology market, Avalon GloboCare competes with manufacturers of urine based ketone test strips and other breath ketone monitoring devices; while it benefits from being the sole North American distributor of the Keto Air device and from its non invasive reusable design, it faces rivals that possess greater financial resources, broader distribution networks and stronger brand recognition. In the artificial intelligence content technology space, the company contends with established technology companies and early stage startups offering AI powered video tools; its platform aims to differentiate through end to end automation of video creation, from topic input to final output, although many competitors have larger research and development budgets, more extensive data assets and established relationships with major social media platforms.

The company sells the Keto Air breathalyzer directly to individual consumers who monitor ketosis levels for dietary or fitness purposes and supplies the device through its partnership with the Law Enforcement Association of America; its AI platform currently serves a beta group of content creators such as podcasters and is intended to expand to a wider audience that includes social media influencers, marketers and businesses involved in product promotion and e commerce. The firm continues to assess market demand and refine its marketing approach through social media channels and direct outreach.